Molecular identification and antifungal susceptibility in clinical isolates of Aspergillus species
Li-li ZHANG,Qiang-xiong WANG,Liang-liang SHEN,Yan-fen JI,Shu-wen DENG,Jing-jun ZHAO
DOI: https://doi.org/10.16118/j.1008-0392.2018.01.014
2018-01-01
Abstract:Objective To investigate the molecular identification and susceptibility to antifungal agents of clinical isolates of Aspergillus species.Methods Fifty-three clinical isolates of Aspergillus were identified to species level based on Internal Transcribed Spacer (ITS) and β-tubulin gene sequencing.The in vitro susceptibility to anidulafungin,caspofungin,micafungin,posaconazole,voriconazole,itraconazole and amphotericin B was tested by CLSI M38-A2.Results Among 53 isolates,there were 21 strains of Aspergillus fumigatus,16 of Aspergillus tubingensis,5 of Aspergillus niger,4 of Aspergillus flavus,4 of Aspergillus terreus,2 of A.welwitschiae and 1 of A.lentulus.The MIC90 of micafungin,anidulafungin,caspofungin,posaconazole,voriconazole,itraconazole,amphotericin B were 0.031,0.031,0.25,0.5,0.5,1 and 2 μg/mL.One Aspergillus fumigatus strain showed resistance to itraconazole and voriconazole.Aspergillus lentulus strain was resistant to Amphotericin B.Other strains were sensitive to 7 antifungal angents.The susceptibility of 4 species complexes to different antifungal drugs was statistically significant differences (P<0.05).Conclusion Echinocandins drugs have best antifungal activity against 5 Aspergillus species,followed by asoles and amphotericin B.Different species of Aspergillus show different patterns of antifungal susceptibility.